Day-Care, Painless, Precise: The Promise of ZAP-X® in Neuro-Oncology

AIG Hospitals has introduced the ZAP-X® Gyroscopic Neuro-Radiosurgery® Platform, the first of its kind in South India and only the second in India, marking a major advance in treating brain tumors and complex neurological conditions. Purpose-built for intracranial radiosurgery, ZAP-X treats brain lesions with sub-millimeter precision, eliminating the need for open surgery and incisions. It delivers highly focused radiation to tumors while sparing healthy tissue, offering patients a fully non-invasive, virtually painless, day-care procedure with rapid recovery.

According to Precedence Research, the Day Case Surgery Market was valued at USD 72.10 billion in 2025 and is projected to grow from USD 76.79 billion in 2026 to approximately USD 135.34 billion by 2035, expanding at a CAGR of 6.50% from 2026 to 2035, driven by increasing disease prevalence and outpatient treatment demand.

Non-Invasive Radiosurgery Advancing Brain Tumor Care in India

Brain tumors and related neurological disorders are an increasing health burden in India. Traditionally, many of these conditions have required complex neurosurgery involving craniotomy, prolonged hospitalization, and lengthy recovery. Stereotactic radiosurgery has emerged globally as a safer alternative for selected cases, and the introduction of the ZAP-X® system at AIG Hospitals brings one of the world’s most advanced neuro‑radiosurgical technologies to patients in South India.

ZAP-X: Precision, Non-Invasive Neurosurgery for Complex Brain Conditions

AIG Hospitals aims to make advanced medical technologies accessible and patient centric. The ZAP-X Gyroscopic Radiosurgery Platform enables conditions that once required major brain surgery to be treated with high precision as a non-invasive, day-care procedure, reducing trauma and recovery time while strengthening Hyderabad’s role as a neurological care hub. ZAP-X treats a wide range of intracranial conditions, including benign and malignant tumors, brain metastases, AVMs, trigeminal neuralgia, and other complex disorders. It is especially impactful for brain metastases, precisely targeting tumor deposits while sparing healthy tissue, and shows promise for functional disorders such as movement disorders and depression. By precisely targeting tumors while sparing healthy tissue, and opening new possibilities for treating complex functional disorders, ZAP-X is redefining what’s possible in brain tumor care.

A recent report by Precedence Research highlights that the Day Case Surgery is benefiting from the rising adoption of healthcare technological advancements.